DE69522960T2 - Verfahren zur herstellung von substituierten 4-ethylpiperidinen - Google Patents

Verfahren zur herstellung von substituierten 4-ethylpiperidinen

Info

Publication number
DE69522960T2
DE69522960T2 DE69522960T DE69522960T DE69522960T2 DE 69522960 T2 DE69522960 T2 DE 69522960T2 DE 69522960 T DE69522960 T DE 69522960T DE 69522960 T DE69522960 T DE 69522960T DE 69522960 T2 DE69522960 T2 DE 69522960T2
Authority
DE
Germany
Prior art keywords
pct
phenyl
ethylpiperidines
sec
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69522960T
Other languages
English (en)
Other versions
DE69522960D1 (de
Inventor
Dan Peters
Oskar Axelsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NTG Nordic Transport Group AS
Original Assignee
Neurosearch AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch AS filed Critical Neurosearch AS
Application granted granted Critical
Publication of DE69522960D1 publication Critical patent/DE69522960D1/de
Publication of DE69522960T2 publication Critical patent/DE69522960T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69522960T 1994-12-21 1995-12-15 Verfahren zur herstellung von substituierten 4-ethylpiperidinen Expired - Lifetime DE69522960T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK145594 1994-12-21
PCT/EP1995/004975 WO1996019452A1 (en) 1994-12-21 1995-12-15 A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same

Publications (2)

Publication Number Publication Date
DE69522960D1 DE69522960D1 (de) 2001-10-31
DE69522960T2 true DE69522960T2 (de) 2002-03-28

Family

ID=8105014

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69522960T Expired - Lifetime DE69522960T2 (de) 1994-12-21 1995-12-15 Verfahren zur herstellung von substituierten 4-ethylpiperidinen

Country Status (7)

Country Link
US (1) US5892047A (de)
EP (1) EP0799201B1 (de)
AT (1) ATE206113T1 (de)
AU (1) AU4304596A (de)
DE (1) DE69522960T2 (de)
FI (1) FI972530A (de)
WO (1) WO1996019452A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
SE0103818D0 (sv) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (sv) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02125410A (ja) * 1988-11-04 1990-05-14 Nippon Chemicon Corp 電解コンデンサ用電解液
MX9100513A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists

Also Published As

Publication number Publication date
FI972530A (fi) 1997-08-13
WO1996019452A1 (en) 1996-06-27
EP0799201A1 (de) 1997-10-08
AU4304596A (en) 1996-07-10
ATE206113T1 (de) 2001-10-15
FI972530A0 (fi) 1997-06-13
DE69522960D1 (de) 2001-10-31
EP0799201B1 (de) 2001-09-26
US5892047A (en) 1999-04-06

Similar Documents

Publication Publication Date Title
DE69520360T2 (de) Phosphonsäure verbindungen imre herstellung und verwendung
ATE231134T1 (de) Verwendung von dioxomorpholinen zur bekämpfung von endoparasiten, neue dioxomorpholine und verfahren zu ihrer herstellung
DK0790824T3 (da) 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
DE69522960T2 (de) Verfahren zur herstellung von substituierten 4-ethylpiperidinen
DE69433012D1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
ATE18549T1 (de) 1-carboxyalkanoylindolin-2-carbonsaeure-ester, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
ES2145260T3 (es) Mejoras introducidas en sintesis quirales.
PT823909E (pt) Nova quimica heterociclica
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
DK0904270T3 (da) Dihydrobenzofuran og beslægtede forbindelser anvendelige som antiinflammatoriske midler
DE3887102T2 (de) Substituierte Derivate von 20,21-Dinoreburnamenin, Verfahren zur Herstellung und so hergestellte Zwischenprodukte, ihre Verwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammenstellungen.
ATE28858T1 (de) Derivate von n-(methoxyphenacyl)aminen, ihre therapeutische verwendung und verfahren zu ihrer herstellung.
DE59504643D1 (de) Neue phosphanoxide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
ATE159517T1 (de) Verfahren zur herstellung von n-carbonylarylimine als zwischenprodukte in der synthese von therapeutisch aktiven taxol-derivaten
DE69514512D1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE195529T1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
DE69521895D1 (de) Indolderivate als prodrugs von "5-ht1-like" rezeptor agonisten
DE59403035D1 (de) Neue bis(aminomethyl)phosphinsäure-derivate und verfahren zur herstellung von bis(aminomethyl)phosphinsäure-derivaten
DE69614838D1 (de) Verfahren zur herstellung von anhydroecgonin-estern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition